RS49792B - Piperidinylaminoethyl trifluoromethyl cyclic ether compounds as substance pantagonists - Google Patents
Piperidinylaminoethyl trifluoromethyl cyclic ether compounds as substance pantagonistsInfo
- Publication number
- RS49792B RS49792B YUP-294/00A YU29400A RS49792B RS 49792 B RS49792 B RS 49792B YU 29400 A YU29400 A YU 29400A RS 49792 B RS49792 B RS 49792B
- Authority
- RS
- Serbia
- Prior art keywords
- pantagonists
- piperidinylaminoethyl
- substance
- cyclic ether
- ether compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Jedinjenje formule (I): i njegove farmaceutski prihvatljive soli, naznačeno time, što R1 je C1-C6alkil; R2 je vodonik, C1-C6 alkil, halo C1-C6alkil ili fenil; R3 je vodonik ili halo; R4 i RS su nezavisno vodonik,C 1-C6 alkil ili haloC1-C6alkil; i n je 1,2ili 3. Prijava sadrži još 12 zahteva.A compound of formula (I): and pharmaceutically acceptable salts thereof, wherein R 1 is C 1 -C 6 alkyl; R 2 is hydrogen, C 1 -C 6 alkyl, halo C 1 -C 6 alkyl or phenyl; R3 is hydrogen or halo; R 4 and R 5 are independently hydrogen, C 1 -C 6 alkyl or haloC 1 -C 6 alkyl; and n is 1,2 or 3. The application contains 12 more requests.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB9701466 | 1997-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU29400A YU29400A (en) | 2003-02-28 |
RS49792B true RS49792B (en) | 2008-06-05 |
Family
ID=11004634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-294/00A RS49792B (en) | 1997-11-19 | 1998-10-26 | Piperidinylaminoethyl trifluoromethyl cyclic ether compounds as substance pantagonists |
Country Status (40)
Country | Link |
---|---|
US (2) | US20030208079A1 (en) |
EP (1) | EP1032571B1 (en) |
JP (2) | JP3394239B2 (en) |
KR (1) | KR100366902B1 (en) |
CN (1) | CN1173974C (en) |
AP (1) | AP909A (en) |
AR (1) | AR016422A1 (en) |
AT (1) | ATE219078T1 (en) |
AU (1) | AU734218B2 (en) |
BG (1) | BG63969B1 (en) |
CA (1) | CA2310627C (en) |
CO (1) | CO4771153A1 (en) |
CZ (1) | CZ297315B6 (en) |
DE (1) | DE69806045T2 (en) |
DK (1) | DK1032571T3 (en) |
DZ (1) | DZ2655A1 (en) |
EA (1) | EA002621B1 (en) |
ES (1) | ES2177058T3 (en) |
HK (1) | HK1033313A1 (en) |
HR (1) | HRP20000313B1 (en) |
HU (1) | HUP0101112A3 (en) |
ID (1) | ID24240A (en) |
IL (1) | IL135631A0 (en) |
IS (1) | IS2202B (en) |
MA (1) | MA26567A1 (en) |
MY (1) | MY120558A (en) |
NO (2) | NO20002544L (en) |
NZ (1) | NZ503912A (en) |
OA (1) | OA11380A (en) |
PA (1) | PA8463001A1 (en) |
PE (1) | PE20000021A1 (en) |
PL (1) | PL193484B1 (en) |
PT (1) | PT1032571E (en) |
RS (1) | RS49792B (en) |
SK (1) | SK283460B6 (en) |
TN (1) | TNSN98210A1 (en) |
TR (1) | TR200001463T2 (en) |
TW (1) | TW426667B (en) |
UA (1) | UA59417C2 (en) |
WO (1) | WO1999025714A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9812617D0 (en) * | 1998-06-11 | 1998-08-12 | Merck Sharp & Dohme | Therapeutic use |
GB9812662D0 (en) * | 1998-06-11 | 1998-08-12 | Merck Sharp & Dohme | Therapeutic use |
HUP0201135A3 (en) * | 1999-05-06 | 2003-05-28 | Pfizer Prod Inc | Substituted benzolactam compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them |
RS49964B (en) | 1999-05-17 | 2008-09-29 | Pfizer Products Inc., | Process for preparing 2-phenyl-3-aminopyridine,substituted phenyl derivatives thereof,and salts thereof |
PT1178984E (en) * | 1999-05-21 | 2003-06-30 | Pfizer Prod Inc | DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME |
WO2001025233A1 (en) * | 1999-10-07 | 2001-04-12 | Hisamitsu Pharmaceutical Co., Inc. | Piperidine derivatives |
ATE257477T1 (en) * | 1999-10-18 | 2004-01-15 | Pfizer Prod Inc | METHOD FOR PRODUCING CYCLIC PIPERIDINYLAMINOMETHYL-TRIFLUOROMETHYL ETHER DERIVATIVES |
CA2324116A1 (en) * | 1999-10-25 | 2001-04-25 | Susan Beth Sobolov-Jaynes | Nk-1 receptor antagonists and eletriptan for the treatment of migraine |
IL142810A0 (en) * | 2000-05-03 | 2002-03-10 | Pfizer Prod Inc | Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
US20020049211A1 (en) * | 2000-09-06 | 2002-04-25 | Sobolov-Jaynes Susan Beth | Combination treatment for depression and anxiety |
EP1192952A3 (en) * | 2000-09-28 | 2003-03-26 | Pfizer Products Inc. | Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
ES2266416T3 (en) | 2001-08-30 | 2007-03-01 | Pfizer Products Inc. | PROCEDURE FOR THE PREPARATION OF COMPOUNDS 2- (4-ALQUIL-1-PIPERAZINIL) -BENZALDEHIDO AND COMPOSITES OF -BENCILIDENILO AROMATIC REPLACEMENT OF 2-FLUOROBENZALDEHIDO WITH 4-ALQUIL-1-PIPERAZINA SOL. |
US20040001895A1 (en) * | 2002-06-17 | 2004-01-01 | Pfizer Inc. | Combination treatment for depression and anxiety |
CN100406057C (en) * | 2002-08-27 | 2008-07-30 | 免疫再生生物科学有限公司 | Amelioration of effects of cigarette smoke |
US6911544B2 (en) * | 2002-10-23 | 2005-06-28 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine |
US7122700B2 (en) | 2004-07-30 | 2006-10-17 | Xerox Corporation | Arylamine processes |
DE102008000891A1 (en) | 2008-03-31 | 2009-10-01 | Robert Bosch Gmbh | Protection system for machine tools |
NO2729147T3 (en) | 2011-07-04 | 2018-02-03 | ||
JP2021514976A (en) | 2018-02-26 | 2021-06-17 | オスペダーレ・サン・ラッファエーレ・エッセエッレエッレ | NK-1 antagonist for use in the treatment of eye pain |
EP4117673A1 (en) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Treatment of stem cell deficiency |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9317987D0 (en) * | 1993-08-26 | 1993-10-13 | Glaxo Group Ltd | Chemical compounds |
EP0826684B1 (en) * | 1995-03-27 | 2001-11-21 | Hisamitsu Pharmaceutical Co., Inc. | Piperidine derivatives |
RU2156250C2 (en) * | 1995-04-24 | 2000-09-20 | Новартис Аг | Derivatives of chromone, method of their synthesis and pharmaceutical composition |
JP3042894B2 (en) * | 1995-07-07 | 2000-05-22 | ファイザー製薬株式会社 | Substituted benzolactam compounds as substance P antagonists |
TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
US6329396B1 (en) * | 1996-06-10 | 2001-12-11 | Pfizer Inc. | Substituted benzylaminopiperidine compounds |
PT1178984E (en) * | 1999-05-21 | 2003-06-30 | Pfizer Prod Inc | DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME |
ATE257477T1 (en) * | 1999-10-18 | 2004-01-15 | Pfizer Prod Inc | METHOD FOR PRODUCING CYCLIC PIPERIDINYLAMINOMETHYL-TRIFLUOROMETHYL ETHER DERIVATIVES |
-
1998
- 1998-10-21 TW TW087117444A patent/TW426667B/en not_active IP Right Cessation
- 1998-10-26 SK SK723-2000A patent/SK283460B6/en unknown
- 1998-10-26 JP JP2000521096A patent/JP3394239B2/en not_active Expired - Fee Related
- 1998-10-26 ID IDW20000926A patent/ID24240A/en unknown
- 1998-10-26 WO PCT/IB1998/001704 patent/WO1999025714A1/en active IP Right Grant
- 1998-10-26 DK DK98947726T patent/DK1032571T3/en active
- 1998-10-26 CA CA002310627A patent/CA2310627C/en not_active Expired - Fee Related
- 1998-10-26 AU AU94549/98A patent/AU734218B2/en not_active Ceased
- 1998-10-26 HU HU0101112A patent/HUP0101112A3/en unknown
- 1998-10-26 PT PT98947726T patent/PT1032571E/en unknown
- 1998-10-26 CZ CZ20001834A patent/CZ297315B6/en not_active IP Right Cessation
- 1998-10-26 TR TR2000/01463T patent/TR200001463T2/en unknown
- 1998-10-26 NZ NZ503912A patent/NZ503912A/en unknown
- 1998-10-26 UA UA2000042374A patent/UA59417C2/en unknown
- 1998-10-26 DE DE69806045T patent/DE69806045T2/en not_active Expired - Fee Related
- 1998-10-26 AT AT98947726T patent/ATE219078T1/en not_active IP Right Cessation
- 1998-10-26 EA EA200000432A patent/EA002621B1/en not_active IP Right Cessation
- 1998-10-26 RS YUP-294/00A patent/RS49792B/en unknown
- 1998-10-26 CN CNB988112930A patent/CN1173974C/en not_active Expired - Fee Related
- 1998-10-26 ES ES98947726T patent/ES2177058T3/en not_active Expired - Lifetime
- 1998-10-26 EP EP98947726A patent/EP1032571B1/en not_active Expired - Lifetime
- 1998-10-26 IL IL13563198A patent/IL135631A0/en not_active IP Right Cessation
- 1998-11-11 PA PA19988463001A patent/PA8463001A1/en unknown
- 1998-11-16 PE PE1998001112A patent/PE20000021A1/en not_active Application Discontinuation
- 1998-11-17 MA MA25354A patent/MA26567A1/en unknown
- 1998-11-17 MY MYPI98005209A patent/MY120558A/en unknown
- 1998-11-17 AR ARP980105829A patent/AR016422A1/en unknown
- 1998-11-18 DZ DZ980265A patent/DZ2655A1/en active
- 1998-11-18 TN TNTNSN98210A patent/TNSN98210A1/en unknown
- 1998-11-18 CO CO98067902A patent/CO4771153A1/en unknown
- 1998-11-19 AP APAP/P/1998/001402A patent/AP909A/en active
-
2000
- 2000-04-26 IS IS5470A patent/IS2202B/en unknown
- 2000-05-12 OA OA1200000138A patent/OA11380A/en unknown
- 2000-05-15 BG BG104437A patent/BG63969B1/en unknown
- 2000-05-17 HR HR960576A patent/HRP20000313B1/en not_active IP Right Cessation
- 2000-05-18 NO NO20002544A patent/NO20002544L/en not_active Application Discontinuation
- 2000-05-18 PL PL98340642A patent/PL193484B1/en unknown
- 2000-05-18 KR KR10-2000-7005431A patent/KR100366902B1/en not_active IP Right Cessation
-
2001
- 2001-06-08 HK HK01103947A patent/HK1033313A1/en not_active IP Right Cessation
-
2002
- 2002-06-18 JP JP2002177452A patent/JP2003040777A/en active Pending
-
2003
- 2003-04-21 US US10/419,425 patent/US20030208079A1/en not_active Abandoned
-
2004
- 2004-07-07 NO NO20042879A patent/NO20042879L/en not_active Application Discontinuation
- 2004-11-18 US US10/991,977 patent/US20050171354A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49792B (en) | Piperidinylaminoethyl trifluoromethyl cyclic ether compounds as substance pantagonists | |
YU48995B (en) | Quinuclidine derivatives | |
YU17591A (en) | TRIAZOLNI FUNGICIDNI AGENCY | |
TR200003524T2 (en) | Use of compounds to increase pyruvate dehydrogenase activity | |
FI841181A0 (en) | NYA N-PHENYL-N'- CYCLOALKYLALKANOYLPIPERAZINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. | |
RS49997B (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
RS49965B (en) | Substituted bisindolymaleimides for the inhibition of cell proliferation | |
RS51193B (en) | Hydantoin derivatives useful as metalloproteinase inhibitors | |
HRP20000508B1 (en) | Substituted 2-benzylamino-2-phenyl-acetamide compounds | |
RS50229B (en) | Vitamin d3 analogs | |
DK1447400T3 (en) | Bicyclic compound | |
HRP20040230B1 (en) | Muscarinic agonists | |
ATE15890T1 (en) | A FUNGICIDAL INDANYL BENZAMIDE. | |
FI812804L (en) | 2- (1,4-BENZODIOXAN-2-YLALKYL) -IMIDAZOLER ANVAENDBARA SOM ANTIDEPRESSIVE CEILING MODEL | |
NO177995C (en) | Analogous process for the preparation of therapeutically active 1,3-dioxane derivatives | |
RS50432B (en) | Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same | |
FI945582A (en) | Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their formulation and use as antiepileptic, neuroprotective and antidepressant agents | |
KR960037677A (en) | 4-indolylpiperazinyl derivative | |
DK1165485T3 (en) | Process for the preparation of pesticide intermediates | |
RS50399B (en) | Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity | |
CO5261576A1 (en) | COMPOUNDS | |
MXPA04003086A (en) | A process for the stereoselective synthesis of 2-hydroxymethyl-chromans. | |
TR200001122T2 (en) | Biphenyl derivatives as pharmaceuticals. | |
FR2737207B1 (en) | NOVEL N-HETEROCYCLYL-1-ARYLOXYALCOYL-4-PIPERIDINAMINES SUBSTITUTED, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
TR199800958A2 (en) | Herbicidal 3,5-Difloropridinleri. |